We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VTRS market cap is 11.06B. The company's latest EPS is USD 0.0458 and P/E is 201.31.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 3.97B | 3.84B | 3.66B | 3.8B | 3.75B |
| Operating Income | 451.7M | -418M | 203.9M | -239.9M | 225.9M |
| Net Income | 331.6M | -765.6M | 113.9M | -326.4M | 94.8M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.95B | 17.89B | 16.26B | 15.43B |
| Operating Income | -259.2M | -95.9M | 1.61B | 766.2M |
| Net Income | -669.9M | -1.27B | 2.08B | 54.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 48.74B | 47.69B | 47.34B | 45.33B | 44.75B |
| Total Liabilities | 27.88B | 27.22B | 27.33B | 25.81B | 24.96B |
| Total Equity | 20.87B | 20.47B | 20.01B | 19.52B | 19.79B |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.55B | 54.84B | 50.02B | 47.69B |
| Total Liabilities | 38.6B | 34.35B | 28.95B | 27.22B |
| Total Equity | 22.95B | 20.49B | 21.07B | 20.47B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | 2.32B | 2.8B | 614.6M | 993.7M | 1.82B |
| Investing | -879.9M | -764.1M | -154.3M | 221.5M | 1.97B |
| Financing | -1.38B | -2.3B | -425.6M | -1.27B | -2.91B |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.23B | 3.02B | 2.95B | 2.8B |
| Investing | -301.1M | -117.8M | 1.52B | -764.1M |
| Financing | -605.7M | -3.01B | -3.88B | -2.3B |
| Market Cap | 11.06B |
| Price to Earnings Ratio | 201.31 |
| Price to Sales Ratio | 0.71 |
| Price to Cash Ratio | 11.1 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | 5.18% |
| Shares Outstanding | 1.19B |
| Average Volume (1 week) | 16.53M |
| Average Volume (1 Month) | 11.35M |
| 52 Week Change | -29.83% |
| 52 Week High | 13.55 |
| 52 Week Low | 8.7701 |
| Spread (Intraday) | 0.05 (0.54%) |
| Company Name | Viatris Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.viatris.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
